Matches in SemOpenAlex for { <https://semopenalex.org/work/W2019910913> ?p ?o ?g. }
- W2019910913 endingPage "5311" @default.
- W2019910913 startingPage "5284" @default.
- W2019910913 abstract "Transthyretin (TTR) is a homotetrameric protein that circulates in plasma and cerebral spinal fluid (CSF) whose aggregation into amyloid fibrils has been associated with at least two different amyloid diseases: senile systemic amyloidosis (SSA) and familial amyloid polyneuropathy (FAP). In SSA aggregates are composed of WT-TTR, while in FAP more than 100 already-described variants have been found in deposits. Until now, TTR-related diseases have been untreatable, although a new drug called Tafamidis has been approved only in Europe to specifically treat V30M patients. Thus, new strategies are still necessary to treat FAP caused by other variants of TTR. TTR has two channels in the dimer interface that bind to the hormone thyroxin and that have been used to accommodate anti-amyloidogenic compounds. These compounds stabilize the tetramers, rendering TTR less amyloidogenic. Here, we investigated the effects of three non-steroidal anti-inflammatory compounds-sulindac (SUL), indomethacin (IND) and lumiracoxib (LUM)-as tetramer stabilizers and aggregation inhibitors. WT-TTR and the very aggressive TTR variant L55P were used as models. These compounds were able to stabilize TTR against high hydrostatic pressure (HHP), increasing the ΔGf by several kcal. They were also effective in inhibiting WT-TTR and L55P acid- or HHP-induced aggregation; in particular, LUM and IND were very effective, inhibiting almost 100% of the aggregation of both proteins under certain conditions. The species formed when aggregation was performed in the presence of these compounds were much less toxic to cells in culture. The crystal structures of WT-TTR bound to the three compounds were solved at high resolution, allowing the identification of the relevant protein:drug interactions. We discuss here the ligand-binding features of LUM, IND and SUL to TTR, emphasizing the critical interactions that render the protein more stable and less amyloidogenic." @default.
- W2019910913 created "2016-06-24" @default.
- W2019910913 creator A5025858582 @default.
- W2019910913 creator A5026851625 @default.
- W2019910913 creator A5027017783 @default.
- W2019910913 creator A5037403938 @default.
- W2019910913 creator A5042219120 @default.
- W2019910913 creator A5076138614 @default.
- W2019910913 date "2013-03-06" @default.
- W2019910913 modified "2023-09-23" @default.
- W2019910913 title "Inhibition of Human Transthyretin Aggregation by Non-Steroidal Anti-Inflammatory Compounds: A Structural and Thermodynamic Analysis" @default.
- W2019910913 cites W112323419 @default.
- W2019910913 cites W1560285331 @default.
- W2019910913 cites W1579462161 @default.
- W2019910913 cites W1691536622 @default.
- W2019910913 cites W1815405126 @default.
- W2019910913 cites W1964480681 @default.
- W2019910913 cites W1967144890 @default.
- W2019910913 cites W1968324562 @default.
- W2019910913 cites W1970646945 @default.
- W2019910913 cites W1971840315 @default.
- W2019910913 cites W1975904672 @default.
- W2019910913 cites W1978617962 @default.
- W2019910913 cites W1979219069 @default.
- W2019910913 cites W1979704176 @default.
- W2019910913 cites W1983870655 @default.
- W2019910913 cites W1984701286 @default.
- W2019910913 cites W1986191025 @default.
- W2019910913 cites W1988352449 @default.
- W2019910913 cites W1993241304 @default.
- W2019910913 cites W2000291757 @default.
- W2019910913 cites W2009484027 @default.
- W2019910913 cites W2015219413 @default.
- W2019910913 cites W2015654033 @default.
- W2019910913 cites W2019261756 @default.
- W2019910913 cites W2022945618 @default.
- W2019910913 cites W2023014768 @default.
- W2019910913 cites W2024615249 @default.
- W2019910913 cites W2025112049 @default.
- W2019910913 cites W2042159493 @default.
- W2019910913 cites W2047046753 @default.
- W2019910913 cites W2058655080 @default.
- W2019910913 cites W2060449610 @default.
- W2019910913 cites W2064278776 @default.
- W2019910913 cites W2064674376 @default.
- W2019910913 cites W2065835715 @default.
- W2019910913 cites W2066486669 @default.
- W2019910913 cites W2076842086 @default.
- W2019910913 cites W2079055683 @default.
- W2019910913 cites W2081954759 @default.
- W2019910913 cites W2085463285 @default.
- W2019910913 cites W2086319950 @default.
- W2019910913 cites W2087500715 @default.
- W2019910913 cites W2092979390 @default.
- W2019910913 cites W2093861673 @default.
- W2019910913 cites W2094309420 @default.
- W2019910913 cites W2094587801 @default.
- W2019910913 cites W2097493124 @default.
- W2019910913 cites W2102465370 @default.
- W2019910913 cites W2111555162 @default.
- W2019910913 cites W2114367386 @default.
- W2019910913 cites W2115752553 @default.
- W2019910913 cites W2115921407 @default.
- W2019910913 cites W2124026197 @default.
- W2019910913 cites W2125511990 @default.
- W2019910913 cites W2141499205 @default.
- W2019910913 cites W2142822529 @default.
- W2019910913 cites W2144688054 @default.
- W2019910913 cites W2152814571 @default.
- W2019910913 cites W2154119752 @default.
- W2019910913 cites W2156984718 @default.
- W2019910913 cites W2158907165 @default.
- W2019910913 cites W2159211495 @default.
- W2019910913 cites W2161532460 @default.
- W2019910913 cites W2169280166 @default.
- W2019910913 cites W2171753345 @default.
- W2019910913 cites W2312608249 @default.
- W2019910913 cites W2329183655 @default.
- W2019910913 cites W30870368 @default.
- W2019910913 cites W4322701596 @default.
- W2019910913 doi "https://doi.org/10.3390/ijms14035284" @default.
- W2019910913 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3634512" @default.
- W2019910913 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23466880" @default.
- W2019910913 hasPublicationYear "2013" @default.
- W2019910913 type Work @default.
- W2019910913 sameAs 2019910913 @default.
- W2019910913 citedByCount "18" @default.
- W2019910913 countsByYear W20199109132013 @default.
- W2019910913 countsByYear W20199109132014 @default.
- W2019910913 countsByYear W20199109132015 @default.
- W2019910913 countsByYear W20199109132016 @default.
- W2019910913 countsByYear W20199109132017 @default.
- W2019910913 countsByYear W20199109132018 @default.
- W2019910913 countsByYear W20199109132021 @default.
- W2019910913 crossrefType "journal-article" @default.
- W2019910913 hasAuthorship W2019910913A5025858582 @default.
- W2019910913 hasAuthorship W2019910913A5026851625 @default.
- W2019910913 hasAuthorship W2019910913A5027017783 @default.